The company received approval for the specific design of ClearPath, its breast brachytherapy, or internal radiation, product. The low-dose rate version was approved in April. Brachytherapy uses radioactive seeds placed through the breast using needles or catheters.
Shares of North American Scientific rose 6 cents, or 5.4 percent, to $1.16 on the Nasdaq in morning trading. The stock has traded between 1 cent and $3 over the last 52 weeks, and is off 49 percent since the start of the year.
source - BusinessWeek